2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term

M. El Ters, L. Cornell, E. Rodrigo, M. Keddis, A. Muriithi, M. Stegall, F. Cosio
Histopathologic Predictors of Kidney Allograft Outcome in Patients with Transplant Glomerulopathy

R. John, N. Mohamed, J. Kim
Histopathologic Scoring and Outcomes in Transplant Glomerulopathy (TG)

R. Najjar, J. Kahwaji, D. Kancherla, A. Peng, R. Villicana, S. Jordan, A. Vo, M. Haas
History of Chronic Opioid Usage and Early Post Transplant Outcomes

S. Kulshrestha, F. Barrantes, M. Kommareddi, M. Samaniego, F. Luan
HLA Antibody Increase Associated with Cardiac Surgery

P. Warner, G. Aldea, M. Gallagher, K. Nelson
HLA Class I Antibody Augments FGF-23 Induced Transplant Vasculopathy and Chronic Antibody Mediated Rejection

E. Tsai, Y. Jin, K. Wesseling-Perry, I. Salusky, R. Ettenger, E. Reed
HLA Class II Mismatch Is Associated with Higher Incidence of Antibody Mediated Rejection after Heart Transplantation

A. Saidi, G. Snow, K. Brunisholz, E. Hammond, O. Wever-Pinzon, S. Drakos, C. Selzman, P. Revelo, R. Alharethi, D. Miller, J. Nativi-Nicolau, B. Reid, D. Budge, E. Gilbert, A. Kfoury, J. Stehlik
HLA Identical Renal Transplant Tolerance with Donor Hematopoietic Stem Cells Absent Chimerism: T and B Regulatory Cell and Genomic Analysis

J. Leventhal, J. Mathew, D. Salomon, S. Kurian, M. Suthanthiran, A. Tambur, J. Friedewald, Y. Kanwar, M. Abecassis, J. Miller
HLA-Antigens as a Risk Factor in Polyomavirus BK Viremia

P. Randhawa, T. Ninomiya, K. Masutani
HLA-DQ Mismatch Is an Independent Predictor of De Novo Donor-Specific HLA Antibodies after Liver Transplantation

H. Kaneku, J. O'Leary, N. Bañuelos, L. Jennings, B. Susskind, G. Klintmalm, P. Terasaki

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z